Media Coverage

Charles River Invests in Resero Analytics

illustration of computer circuit board

Drug Discovery News

Charles River Laboratories announced that it had invested in Resero Analytics, a software company focused on providing solutions to the biopharmaceutical industry to harness its data. As part of its investment, Charles River will collaborate with Resero Analytics and is now the exclusive contract research organization (CRO) partner for TurboToxicology, a report-generation tool that enables faster delivery of high-quality reports.

Read the Full Article